Related Experiment Video
Updated: May 16, 2026
06:39
Real-Time Void Spot Assay
Published on: February 10, 2023
Simvastatin suppresses cyclophosphamide-induced changes in urodynamics and bladder inflammation
Francis M Hughes1, Paige McKeithan, Justin Ellett
1Department of Urology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Urology
|November 17, 2012
Summary
Daily simvastatin effectively reduced bladder dysfunction and inflammation caused by cyclophosphamide (CP) chemotherapy in rats. This suggests simvastatin could be a potential therapy to prevent chemotherapy-induced cystitis side effects.
Area of Science:
- Urology
- Pharmacology
- Oncology
Background:
- Cyclophosphamide (CP) chemotherapy can cause cystitis, leading to urinary dysfunction and bladder hemorrhage.
- Statins, including simvastatin, have demonstrated anti-inflammatory properties and potential uroprotective effects.
- Understanding these effects is crucial for managing chemotherapy side effects.
Purpose of the Study:
- To evaluate the efficacy of daily oral simvastatin in mitigating urodynamic changes associated with CP-induced cystitis.
- To determine if simvastatin can prevent bladder inflammation resulting from CP administration.
Main Methods:
- Four groups of female Sprague-Dawley rats were used: control, simvastatin alone, CP alone, and simvastatin plus CP.
- Urodynamic properties were assessed, and bladder inflammation was measured using Evans blue extravasation.
Main Results:
- CP significantly increased nonvoiding contractions and decreased peak voiding pressure, which simvastatin normalized.
- Simvastatin also restored CP-induced changes in voided volume to control levels.
- CP-induced bladder inflammation was significantly suppressed by simvastatin treatment.
Conclusions:
- Daily oral simvastatin effectively ameliorated negative urodynamic changes and bladder inflammation following CP administration.
- Simvastatin shows promise as a potential therapeutic agent for preventing chemotherapy-induced cystitis.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Imaging Studies VI: Voiding Cystourethrography and Cystography
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...